Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Trials in a Crunch

With the increasing budgetary challenges of running a drug development program, it's no wonder that one of the first places to feel the pinch is in programs for rare diseases. Clinical trials of therapeutics for these illnesses are having so much trouble finding cash that some companies are asking enrolled patients to help foot the bill, according to this article in the Wall Street Journal.

 

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.